Actionable news
0
All posts from Actionable news
Actionable news in NVLS: NOVELLUS SYSTEM ORD,

Nivalis Therapeutics, Inc.'s See Remarks just declared 216,667 options and restricted shares

David Malcom Rodman, Nivalis Therapeutics, Inc.'s See Remarks, has now declared ownership of 216,667 options and restricted shares from the company. The strike prices of the options received ranged from $0.00 to $4.68, and these expire on April 18, 2026. The restricted shares don't become available to Rodman until such time as they become vested.

Some additional info was provided as follows:

The options vest and become exercisable over a four-year period, with 25% vesting on the first anniversary of the grant date (April 18, 2017) and 1/48th of the options vesting monthly thereafter. The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant of April 18, 2016. Each Restricted Stock Uni t represents the contingent right to receive one share of Common Stock. The restricted stock units vest in 12 equal installments on the first day of each calendar quarter commencing on July 1, 2016, subject to the reporting person's continued service with the company.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Nivalis Therapeutics, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Nivalis Therapeutics Appoints David Rodman, Md As Chief Medical Officer And Executive Vice President Of Discovery - April 22, 2016
Nivalis Therapeutics Reaches 50 Percent Enrollment Milestone In Phase 2 - April 5, 2016
Nivalis Therapeutics, Inc.'s President and CEO just picked up 5,000 shares - March 25, 2016